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Summary: The aim of this study was to define the optimal conditions for the plasma pretreatment and to
improve the production of Standard curves for plasma endotoxin detennination by a Chromogenic Substrate
assay. Endotoxin Standard from E. coli O 111: B 4 (0—50 ng/1) was added to pyrogen-free water or to plasma
samples from 12 healthy subjects and 24 alcoholics, before pretreatment by heating (75 °C, 5 minutes) or with
perchloric acid (0.32 mol/1). When endotoxin Standard curves were determined using a microprocessor-
controlled reader, the slopes of the curves obtained with plasma differed from those with pyrogen-free water.
The slope of the Standard curve prepared with plasma samples from different patients exhibited marked
interindividual variations. Compared with the heating method, the perchloric acid method gave more variable
results and a lower recovery of added endotoxin, especially in plasma from alcoholics. The results permit the
following conclusion:
1. For plasma endotoxin determination, a Standard curve should be prepared for each individual plasma
sample.
2. The endotoxin Standard should be added before pretreatment of the plasma.
3. Pretreatment of the plasma by heating at 75 °C for 5 minutes provides more reliable results than pretreatment
with perchloric acid.
Introduction , - . . - . . , . , . . .procedures aimed at avoiding mhibitory activities in
Numerous studies on the determination of endotoxin plasma, dilutioii and heating (9, 10) and perchloric
in human plasma have been published (l, 2). Most acid treatment (11) have been widely used. Studies
have been performed using different variations of the comparing these methods (11,12) have produced con-
classical Limulus lysate test (measurement of gel for- flicting results.
mation). The prpblems associated with this procedure The aim rf ̂  was to defme ̂  ,
have been discussed m deta dsewhere (3). For quan- rf ob standard ̂ ^ ̂  & chromogenic assay
titative meas rements of endotoxin in plasma, a j * " ι * ' i * * j. * t Λ Μ j t_ τ and to re-evaluate plasma pretreatment procedures.chromogenic method h s been descnbed by Japanese
authors (4). Although the chromogenic assay has been
shown to give reliable results for minute amounts of
endotoxin in water (4), meas rements in Wood still Materials and Methods
present difficulties. Firstly, there is still disagreement 1 Sub-ects
about the best way of preparing Standard curves
(5-8) and «condly, a„ opttaat method for elimi- Χ^^Τ15ΪΑ'*ΑΑ«Μ?Αί5
nating plasma Inhibitors in the endotoxin assay has liver an^ 17 wilh ^VQT cirrhosis, age r nge 60 to 65 years). The
not yet been established. Among various pretreatment diagnosis was based on liver biopsy in aU cases.
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2. Blood sampling
After cleaning the skin twice with aqueous ethanol, volume
fraction 0.6 and with Kodan-spray (Schülke & Mayr GmbH,
Norderstedt, F. R. G.), 3 ml blood samples were collected from
the antecubital vein into pyrogen-free syringes containing 75
units of NH4-heparin äs previously described (13). Gare was
taken to avoid air bubbles in the syringes. Platelet-rich plasmä
was prepared by centrifugation at 150g for 20 min at 0°C.
The separated plasmä was stored at -80°C in pyrogen-free
polyethylene tubes (Eppendorf, Hamburg, F. R. G.)·
3. Chromogenic assay
Hydrolysis of the Chromogenic Substrate was determined in two
difierent ways: firstly äs described in the original method used
(6) by incubation for three minutes and stopping the reaction
with acetic acid (endpoint determination), and secondly by
checking the linearity of the indicator reaction used in the test
by measuring hydrolysis kinetics of the chromogenic Substrate
(continuous assay).
3.1 Endpoint determination
Endotoxin was measured in plasmä by a modification of the
chromogenic Substrate test (Kabi-Vitrum, Stockholm, Sweden)
äs described by Friberger et al. (6). The plasmä was diluted
l :10 with ice-cold pyrogen-free water. In order to prepare a
large number of samples for parallel incubation, the diluted
plasmä samples were allowed to stand for a maximum of 30
minutes on ice. Storage of these plasmä samples, diluted 1:10
on ice, resulted in no loss of endogenous or added endotoxin
over a period of up to two hours. The diiuted plasmä samples
were then heated for 5 min at 75 °C. Fifty of Limulus amoe-
bocyte lysate was added to 50 of the heated plasmä. After a
preincubation time of 25 min (37 °C), 100 of Substrate (S-
2423, Ac-Ile-Glu-Gly-Arg-/?-nitroanilide, 1.4 mmol/1) dissolved
in Tris buffer (25 mmol/1, pH 9.0) were added and incubated
at 37 °C for exactly 3 min. The reaction was stopped by adding
100 3.3 mol/1 acetic acid. Absorbance was measured at 405
nm. The test was performed in sterile polyethylene tubes. All
procedures were performed in a laminar flow bank (Captair
2004, Hermann Waldner KG, Wangen im Allgäu, F. R. G.). In
accordance with the instructions provided by the manufacturer
all determinations were performed in dupiicate.
Two blank values were run in parallel with each test: one in
which the same volume of pyrogen-free water was added instead
of 50 diluted plasmä, and a second with which the intrinsic
absorbance of the plasmä was to be measured, and in which
Limulus amoebocyte lysate was replaced by 50 pyrogen-free
water. Otherwise, the two blank values were treated in the same
way äs the plasmä measurement values.
4. Standard curves and calculation of endogenous
endotoxin
Endotoxin Standards were prepared from E. coli O111:B4
(Kabi Vitrum, Stockholm, Sweden; l ng = 12 endotoxin units
(EU). According to the Information of the manufacturer the
endotoxin unit (EU) is determined against the EC5 Standard
of the Food and Drug Administration (FDA) or lot F, USP
reference Standard endotoxin and coiitrolled under FDA licence
No 709. To each 100 l :5 diluted pläima sample, 100 of
pyrogen-free water or 100 of different Standard endotoxin
Solutions (12.5 —100 ng/1) were added before heating. This gave
final endotoxin concentrations of 0, 6.25, 12.5, 25, 37.5 and 50
ng/1. After adding the respective amount of Standard endotoxin
solution, the samples were ice-cooled for a maximum of five
minutes before heating.
To plot the Standard curves, the measured changes in absorb-
ance were used for each Standard value after subtracting the
value for the plasmä sample (with no addition of exogenous
endotoxin Standard).
The endogenous endotoxin concentration was calculated äs
follows:
Endotoxin (103 EU/l) =
[Api — AH2o — Api blank]
0.2 EU/ml - 0.1 EU/ml
x 10
where
Ap, = absorbance for plasmä
AH^O = absorbance for water (both after incubation with
Limulus amoebocyte lysate)
Api blank = absorbance for plasmä blank
AA0.2Eu and AAO.IEU were read off the Standard cürve.
Fraction bar == reciprocal value of the slope of the Standard
curve.
5. Recovery
In order to establish how inuch exogenous endotoxin is lost by
heating, another endotoxin Standard with a final concentration
of 25 ng endotoxin per litre 1:10 diluted plasmä was prepared
by adding endotoxin to each plasmä after heating. The increase
in absorbance in the samples with added endotoxin after heating
was taken äs 100%, and the recovery of the endotoxin added
to the sample before heating was calculated äs the recovered
percentage äs follows:
Recovery % = A/B 100,
where
A = net increase in absorbance in the sample with endotoxin
added before treatment,
B = net increase in absorbance in the sample with endotoxin
added after treatment. In each run of the assay, a Standard
curve in pyrogen-free water was also prepared äs a control.
3.2 Continuous measurement
The kinetics of the enzymatic hydrolysis of the chromogenic
Substrate were measured at 37 °C for 0 — 10 min, using sterile
microtitre plates in a micro-processor controlled reader
(EAR400AT, SLT Lab. Inst., Salzburg, Austria), which was
placed in a laminar flow bank. Preparation of the plasmä
samples (including preincubation and addition of Substrate)
was exactly äs described under 'endpoint determination', with
the sole exception that the volumes were reduced to 40 ul
sample, 40 Limulus amoebocyte lysate and 80 Substrate
buffer. Measurement of the change in the absorbance was
carried out at intervals of 30 seconds at 405 nm.
6. Acid treatment
In order to compare the results obtained with pretreatment of
the plasmä by heating äs described in section 3.1 with those
obtained with the method proposed by Obayashi (11) in which
plasmä is treated with acid before endotoxin determination,
two variations of the test with acid pretreatment were per-
formed äs follows.
6.1 Plasma samples from 22 subjects (8 healthy individuals, 7
alcoholics with fatty liver and 7 alcoholics with liver cirrhosis)
were treated using the original method of Obayashi (l 1). Plasma
(180 ) was mixed with either 20 pyrpgen^free water or
endotoxin Standard solution at a concentration of 0—50 ng
exogenous endotoxin per litre of diluted (3:20) plasmä.
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6.2 11 was considered that recovery might be better if the plasma
was diluted further. Plasma samples (100 μΐ) from the 22 sub-
jects mentioned in 6.1 were mixed with 100 μΐ water or endo-
toxin Standard solution at an exogenous endotoxin concentra-
tion of 0—50 ng per litre of diluted (1:12) plasma.
The diluted plasma samples (200 μΐ) pretreated s described
under 6.1 and 6.2 were mixed with 400 μΐ of 0.32 mol/1 HC1O4,
incubated for 20 min at 37 °C and centrifuged at 1000 g for 15
min at 0 °C. An aliquot (100 μΐ) of each supernatant was
neutralized by adding of 100 μΐ 0.18 mol/l NaOH; tests on 6
plasma samples showed that this treatment resulted in a pH of
7—7.5. Final plasma dilutions were therefore 3:20 and l :12
respectively. Another endotoxin Standard with a final concen-
tration of 25 ng endotoxin per litre plasma (diluted 3:20 or
1:12) was prepared by adding endotoxin to the neutralized
supernatant. The recovery rate of added endotoxin was calcu-
lated s described in section 4. For each run of the assay,
endotoxin Standard (25 ng/1) was prepared in pyrogen-free
water both with and without HC1O4 pretreatment.
7. Self-prepared control samples
To evahiate the Variation in endotoxin concentration over time
from one determination to the next, plasma from a healthy
individual which was both spiked and non-spiked with exoge-
nous endotoxin (25 ng/1) was divided into 0.5 ml portions in
sterile polyethylene tubes and stored at — 80 °C. The above
sample was measured weekly for l month and thereafter in
parallel with every endotoxin determination of the study over
a period of 8 months to obtain a measure of the precision of
the assay and the stability of endotoxin during storage.
8. Statistical analysis
For Statistical evaluation, Wilcoxon-Mann- Whitney*s U-test
was used. The results were expressed s means ± SD.
Results
1. Standard curves
The kinetics of the hydrolysis of the chromogenic
Substrate with endotoxin Standards in water and in
plasma from healthy individuals (fig. 1) was linear
for 3 min. The endogenous endotoxin concentrations
in the plasma from the healthy individuals never ex-
ceeded 60 endotoxin units per litre (=5 ng/1). The
net increase in the absorbance (ΔΑ) obtained in the
plasma samples was 4 to 5 times greater than that
observed in water. When endotoxin Standards were
added to plasma fr m two patients with very high
endogenous endotoxin concentrations (> 2400 endo-
toxin units per litre = > 200 iig/1), deviations from
linearity were seen after 2 and 2.5 min, respectively.
The slope of the Standard curve in each plasma ex-
hibited marked mterindividual Variation, particularly
in the alcoholics (fig. 2). Each Standard curve was
linear up to 37.5 ng endotoxin per litre of diluted
(1:10) plasma (corresponding to a final concentration






Fig. l. Kinetics of the hydrolysis of the chromogenic Substrate
by endotoxin Standards in distilled pyrogen-free water
(o o) and in plasma (x—x) from a healthy subject,
using microtitre plates. The net increase in absorbance
(AA4osmm) was obtained by subtracting the value of
water or plasma without endotoxin. The assay was


















Fig. 2. Standard curves of endotoxin in plasma samples of 5
healthy subjects (a) and 5 patients with alcoholic liver
disease (b). Determinations were performed using the
endpoint determination (sample volume: 50 μΐ). Note
the marked Variation of the slope of the Standard curves
in the group with alcoholic liver disease.
Linearity was also observed up to 3 min for samples
with endotoxin concentrations up to 50 ng per litre
diluted (1:10) plasma when the hydrolysis of the
chromogenic Substrate was measured continuously
(fig. 1). For the two plasma samples containing very
high endogenous endotoxin concentrations, the linear
parts of the kinetic curves were extrapolated to 3 min
and used to draw Standard curves.
2. Recovery of endotoxin by the heating
method
The recovery of added endotoxin was 91.3 ± 13.3%
(mean ± SD) in plasma from controls (fig. 3), and
89.8 ± 15.1% in plasma from the total group of
alcoholics. The recovery rate in plasma from cirrhotics
(87.4 ± 17.3%) was not significantly different from
that in plasma from patients with fatty liver (95.7
± 4.4%).
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Fig. 3. Comparison of the three different procedures for elim-
inating factors interfering with the endotoxin determi-
nation using a chromogenic Substrate. The recovery
rates of endotoxin Standard with these procedures were
compared in plasma samples obtained by the heating
method from 12 healthy subjects (normal), 7 patients
with alcoholic fatty liver and 17 patients with alcoholic
cirrhosis.
For both methods using perchloric acid, the number of
subjects in the three troups was 8, 7 and 7, respectively.
D normal Q fatty liver Q cirrhosis
3. Recovery of endotoxin by the HC1O4
method
The recovery of added endotoxin was highly variable,
both in plasma from controls (44.3 ± 27.0%) and in
plasma from alcoholics with cirrhosis (58.5 ± 29.5%)
when the acid method l (final plasma dilution 3:20)
was used. There was no significant difference in the
recovery rates between healthy subjects and the two
groups with alcoholic liver disease (fig. 3). The recov-
ery rates of endotoxin in plasma both from controls
and alcoholics with this method were significantly
lower (P < 0.005, P < 0.01) than those obtained with
the heating method.
The recovery of added endotoxin from plasma sam-
ples of controls was 84.3 + 22.9% when acid method
2 (final plasma dilution 1:12) was used. Using this
method, the recovery of endotoxin from plasma of
alcoholics with fatty liver varied greatly (57.9
± 27.6%) and was lower than in healthy subjects
(P < 0.05). The lowest recovery rate was noted in
cirrhotics (11.6 ± 7.5%). The recovery rates of endo-
toxin in plasma from patients with fatty liver and
from cirrhotics by this method were significantly
lower than those obtained with the heating method
(P < 0.025, P < 0.005) (fig. 3).
4. The endotoxin Standard in water
Endotoxin Standards (25 ng/1) in pyrogen-free water,
always gave lower absorbance values than those in
the plasma samples with addition of endotoxin added
before heating (fig. 1).
5. Self-prepared control samples
As shown in figure 4, the values of the self-prepared
control samples remained fairly constant for a period
of almost 8 months. The mean value ± SD of all
determinations of the self-prepared control samples
was 300 + 45 endotoxin units per litre (n = 22). The
results obtained by the endpoiii method (χ ± SD
= 290 ± 26 endotoxin units per litre; n = 10) were
comparable to those obtained by the continuous
measurement using micfotitre plates (x + SD ==312
± 56 endotoxin units per litre; ii = 12). The coeffi-
cient of Variation between days of determination was
15% for all values (n = 22). Related to the periods
when only the "endpoint" or the "continuous"
method was used, the Variation coefficient was 8.9%









Fig. 4. Repeated determinations of endotoxin in the self-pre-
pared control samples. The first 10 determinations were
performed using the endpoint determination (solid cir^
des), the following 12 determinations using the contin-
uous assay (open circles). The dotted line represents the
means ± 2 SD of all determinations.
Discussion
After a sensitive chromogenic Substrate assay had
been developed for the determination of endotoxin
concentration in blood, several authors (5, 7, 10, 12,
14) tried to establish the optimal assay conditions. A
number of important points, such s heparin concen-
tration in plasma, inactivation temperature for inhib-
itors, assay pH, influence of Ca2+, Mg2* or Na+,
stability of lysate and endotoxin Standard, recovery
of added endotoxin from platelet-rich and platelet-
poor plasma have already been exhaustively investi-
gated (5, 7, 10, 12, 15). However, the questions of
how to establish the Standard curve for calc lating
plasma endotoxin concentration and how to pretreat
the plasma sample adequately to minimize binding or
inactivation of endotoxin have not yet been satisfac-
torily resolved (8, 15 — 19). The differences in the
methods used to pretreat plasma and establish stand^
ard curves might influence the results of plasma endo-
toxin determinations in patients with varipus diseases.
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In previous studies on the detennination of endotoxin
in the plasma of patients with various diseases, Stand-
ard curves of endotoxin were prepared either in pyro-
gen-free water (11, 15, 19) or in pooled plasma from
healthy subjects (7). Our own results show that the
kinetics of the hydrolysis of the chromogenic Substrate
in plasma differs from that in pyrogen-free water. The
net increase in absorbance of the plasma was 4 to 5
times greater than that of water. Harris et al. (12)
also reported higher absorbance readings with dilu-
tions of endotoxin in plasma compared with similar
dilutions in water, and supposed that a physicochem-
ical change of endotoxin in plasma might lead to
enhanced reactivity. On the basis of these results, we
suggest that Standard curves in water should not be
used for the calculation of endotoxin concentration
in plasma. The present study further reveals that the
Standard curve in each plasma sample exhibits marked
interindividual Variation. Since the slope of the Stand-
ard curve varies greatly, endotoxin plasma concentra-
tion in each patient must be calculated from its own
individual Standard curve. Calculations performed us-
ing a common Standard curve prepared for pooled
plasma will frequently lead to false results. Urbaschek
et al. (20) also emphasized this point on the basis of
their results in a densitometric kinetic Limulus lysate
microtitre test.
In the present study, we have been able to show that
the mean recovery rate of exogenous endotoxin with
the heating method was about 90% and generally
satisfactory both in control plasma and in plasma
from patients. But the fact that the recovery of ex-
ogenous endotoxin added to the plasma before heat-
ing was usually less than 100% Supports the assump-
tion that the spiking of plasma should be done in
samples both before and after heating. This procedure
permits the calculation of the amount of endogenous
endotoxin lost by heating, and a more accurate cal-
culation of the endotoxin concentration in a given
plasma, The problem mentioned above, namely that
the percentage of endotoxin, bound or inactivated t
the time of blood sampling is not measured (8, 15 —
19), is, however, not resolved in this way.
An endotoxin assay with an individual Standard curve
for each plasma cert inly improves reliability, but
inakes the endotoxin detennination more expensive.
It is therefore reasonable to attempt to reduce sample
and lysate Volume to minimize costs. Using the end-
point assay in plastic tubes, we obtained satisfactory
results with 50 μΐ of samples and lysates. When mi-
crotitre plates were used for the continuous assay a
further volume reduction to 40 μΐ was achieved. A
similar reduction in the volume of plasma and lysate
has been obtained by others (14).
In the present study, the recovery rates of endotoxin
from spiked samples were lower with the HC1O4
method than with the heating method. In contrast to
our study, other authors (11, 19) have reported a
recovery of endotoxin with the HC1O4 method of
almost 100%.
The reason for the discrepancy between this figure
and our own results is difficult to explain. One factor
which might contribute to the high endotoxin recov-
ery by Obayashi (11) and Yajima et al. (19) is the fact
that these authors divided the net increase of absorb-
ance in plasma by that obtained in water to calculate
their recovery rates. We have demonstrated that, for
a given amount of exogenous endotoxin, the increase
in absorbance is higher in neutralized supernatant
from plasma treated with HC1O4 than in the same
volume of water. With their mode of calculation
Obayashi (11) and Yajima et al. (19) might have over-
estimated the percentage recovery rate. It has been
generally accepted that endotoxin activities of lipo-
polysaccharides, including Limulus amoebocyte lysate
gelating activity, are located in their lipid A moiety
(21, 22). Acid hydrolysis has been widely used to
isolate lipid A from various lipopolysaccharides (23 —
25). Therefore, HC1O4 treatment might split at least
a part of endogenous and exogenous endotoxin, lead-
ing to the formation of free lipid A, which would then
be found in the precipitate after centrifugation. In
addition endotoxin bound to protein might also pre-
cipitate. This precipitated part of endotoxin activity
is likely to be missed by the HC1O4 method.
The observed difference in recovery rates for the di-
luted (3:20) plasma s compared with the diluted
(l: 12) plasma, using the HC1O4 method, Supports the
assumption that recovery of endotoxin in the super-
natant depends on the amount of protein or other
compounds that can bind or inactivate endotoxin in
the acidified mixtures.
The results of the detennination in the self-prepared
control samples further support the assumption that
the method described for endotoxin detennination in
plasma has an acceptable level of reproducibility. In
addition, they show that under the conditions of our
study the endotoxin concentration in plasma remains
nearly unchanged for a period of eight months.
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